Effect of the dual sodium‐glucose co‐transporter‐1 and ‐2 inhibitor sotagliflozin on renal outcomes in type 1 diabetes and type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials.
Saved in:
| Title: | Effect of the dual sodium‐glucose co‐transporter‐1 and ‐2 inhibitor sotagliflozin on renal outcomes in type 1 diabetes and type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials. |
|---|---|
| Authors: | Bantounou, Maria Anna1 (AUTHOR) m.bantounou.20@abdn.ac.uk, Sardellis, Panagiotis1 (AUTHOR), Thuemmler, Rosa1 (AUTHOR), Black Boada, Daniel1 (AUTHOR), Kaczmarek, Justyna1 (AUTHOR), Mahmood, Ribeya1 (AUTHOR), Plascevic, Josip1 (AUTHOR), Philip, Sam1,2 (AUTHOR) |
| Source: | Diabetes, Obesity & Metabolism. Feb2024, Vol. 26 Issue 2, p710-720. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
